CORRESP Filing
SciSparc Ltd.
Date: July 18, 2025 · CIK: 0001611746 · Accession: 0001213900-25-065487
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-282351
Letter
SciSparc Ltd.
20 Raul Wallenberg Street, Tower A,
Tel Aviv 6971916, Israel
July 18, 2025
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
RE: SciSparc Ltd. (CIK 0001611746)
Registration Statement No. 333-282351 on Form F-4 (the "Registration Statement")
Ladies and Gentlemen:
SciSparc Ltd. (the " Registrant ") hereby requests acceleration of the effectiveness of the above-referenced Registration Statement pursuant to Rule 461 under the Securities Act of 1933, as amended (the " Securities Act "), so that it may become effective on July 21, 2025 at 9:00 a.m., Eastern Time, or as soon thereafter as is practicable.
The Registrant respectfully requests that it be notified of such effectiveness by a telephone call to Howard E. Berkenblit, Esq. of Sullivan & Worcester LLP at (617) 338 2979 and that such effectiveness also be confirmed in writing.
Very truly yours,
SciSparc Ltd.
Show Raw Text
CORRESP 1 filename1.htm SciSparc Ltd. 20 Raul Wallenberg Street, Tower A, Tel Aviv 6971916, Israel July 18, 2025 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 RE: SciSparc Ltd. (CIK 0001611746) Registration Statement No. 333-282351 on Form F-4 (the "Registration Statement") Ladies and Gentlemen: SciSparc Ltd. (the " Registrant ") hereby requests acceleration of the effectiveness of the above-referenced Registration Statement pursuant to Rule 461 under the Securities Act of 1933, as amended (the " Securities Act "), so that it may become effective on July 21, 2025 at 9:00 a.m., Eastern Time, or as soon thereafter as is practicable. The Registrant respectfully requests that it be notified of such effectiveness by a telephone call to Howard E. Berkenblit, Esq. of Sullivan & Worcester LLP at (617) 338 2979 and that such effectiveness also be confirmed in writing. Very truly yours, SciSparc Ltd. By: /s/ Oz Adler Oz Adler, Chief Executive Officer and Chief Financial Officer